[Gene therapy to cure HIV infection].

IF 0.7 4区 医学 Q4 VIROLOGY Virologie Pub Date : 2023-10-01 DOI:10.1684/vir.2023.1021
Ryan P Goguen, Michelle J Chen, Owen R S Dunkley, Anne Gatignol, Robert J Scarborough
{"title":"[Gene therapy to cure HIV infection].","authors":"Ryan P Goguen, Michelle J Chen, Owen R S Dunkley, Anne Gatignol, Robert J Scarborough","doi":"10.1684/vir.2023.1021","DOIUrl":null,"url":null,"abstract":"<p><p>To date, the only intervention that has cured HIV infection has been bone marrow transplants from HIV-resistant donors to HIV-infected recipients. This approach has been used to both cure hematological malignancies and HIV infection, but it cannot be widely adopted due to the high risk of mortality associated with cell transplants between individuals. To overcome this limitation, several approaches have been developed to generate HIV resistance using gene therapy in an infected individual's own cells. With the growing arsenal of effective methods to generate HIV-resistant cells, a safe and effective combination gene therapy approach to cure HIV infection is fast approaching. Here, we review several gene therapy-based methods to generate HIV-resistant cells including the expression of antiviral genes, genome editing, and transcriptional gene silencing. Their varied mechanisms, advantages, and disadvantages are discussed, and perspectives are provided for how they may be combined to design an effective gene therapy for HIV.</p>","PeriodicalId":49377,"journal":{"name":"Virologie","volume":"27 5","pages":"284-306"},"PeriodicalIF":0.7000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/vir.2023.1021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

To date, the only intervention that has cured HIV infection has been bone marrow transplants from HIV-resistant donors to HIV-infected recipients. This approach has been used to both cure hematological malignancies and HIV infection, but it cannot be widely adopted due to the high risk of mortality associated with cell transplants between individuals. To overcome this limitation, several approaches have been developed to generate HIV resistance using gene therapy in an infected individual's own cells. With the growing arsenal of effective methods to generate HIV-resistant cells, a safe and effective combination gene therapy approach to cure HIV infection is fast approaching. Here, we review several gene therapy-based methods to generate HIV-resistant cells including the expression of antiviral genes, genome editing, and transcriptional gene silencing. Their varied mechanisms, advantages, and disadvantages are discussed, and perspectives are provided for how they may be combined to design an effective gene therapy for HIV.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[基因疗法治疗HIV感染]。
迄今为止,治愈艾滋病毒感染的唯一干预措施是从抗艾滋病毒的供体向感染艾滋病毒的受者进行骨髓移植。这种方法已被用于治疗血液恶性肿瘤和HIV感染,但由于个体间细胞移植相关的高死亡率,它不能被广泛采用。为了克服这一限制,已经开发了几种方法,通过在受感染个体自身细胞中使用基因治疗来产生HIV抗性。随着产生抗HIV细胞的有效方法越来越多,一种安全有效的联合基因治疗方法正在迅速接近。在这里,我们回顾了几种基于基因治疗的方法来产生hiv抗性细胞,包括抗病毒基因的表达,基因组编辑和转录基因沉默。讨论了它们的不同机制、优点和缺点,并就如何将它们结合起来设计有效的HIV基因治疗提供了观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Virologie
Virologie VIROLOGY-
CiteScore
1.20
自引率
22.20%
发文量
31
审稿时长
>12 weeks
期刊介绍: Virologie offers top-level information for all those for whom virology is already the main or an important part of their activity: biologists, clinicians, pharmacists, veterinarians, agronomists, etc.
期刊最新文献
[37th International Conference on Antiviral Research (ICAR)]. [Joint Thesis Award 2023 of the Société française de virologie and ANRS | Maladies infectieuses émergentes]. [XIXe atelier international sur les parvovirus (Leuven, Belgique), 03-06 septembre 2024]. [From viral disease gender to viral species subclassification: how to find our way around?] [Human papillomaviruses : origin, oncogenic factors and markers for cervical cancer screening].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1